On the other hand, tumor size, pT stage, pN stage, tumor location, peripheral VPI and NSE levels, and adjuvant chemotherapy were significantly associated with DFS in C-SCLC by univariate survival analysis (P<0.05 for all, Table 2). Here, ENO2 is linked to small cell lung carcinoma.